Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Jun 05, 2017	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy Filings	View HTML 0001193125-17-194564.pdf 0001193125-17-194564.rtf 0001193125-17-194564.xls
Jun 02, 2020	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy Filings	View HTML 0001193125-20-158605.pdf 0001193125-20-158605.rtf 0001193125-20-158605.xls
Jun 01, 2021	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy Filings	View HTML 0001193125-21-178549.pdf 0001193125-21-178549.rtf 0001193125-21-178549.xls
Aug 19, 2021	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy Filings	View HTML 0001193125-21-251575.pdf 0001193125-21-251575.rtf 0001193125-21-251575.xls
May 31, 2022	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy Filings	View HTML 0001193125-22-164026.pdf 0001193125-22-164026.rtf 0001193125-22-164026.xls
Jan 18, 2012	8-K12B	8-K12B	Other	View HTML 0001193125-12-015521.pdf 0001193125-12-015521.rtf 0001193125-12-015521.xls
Jan 19, 2012	424B7	424B7	Registration Statements	View HTML 0001193125-12-016272.pdf 0001193125-12-016272.rtf 0001193125-12-016272.xls
Mar 07, 2012	424B7	424B7	Registration Statements	View HTML 0001193125-12-101418.pdf 0001193125-12-101418.rtf 0001193125-12-101418.xls
Mar 06, 2013	424B7	424B7	Registration Statements	View HTML 0001193125-13-093883.pdf 0001193125-13-093883.rtf 0001193125-13-093883.xls
Feb 28, 2014	424B7	424B7	Registration Statements	View HTML 0001193125-14-074523.pdf 0001193125-14-074523.rtf 0001193125-14-074523.xls

Data provided by Kaleidoscope.